|
27 October, 2011
|
ICON Reports Q3 revenue growth of 7% to $241 million and net new business of $431 million. (NASDAQ:ICLR) (ISIN:IE0005711209)
|
|
|
07 September, 2011
|
ICON Announces Peter Gray To Retire As CEO
|
|
|
30 August, 2011
|
ICON Selected as a Preferred Provider for Early Phase Clinical Development by Bristol-Myers Squibb
|
|
|
20 July, 2011
|
ICON Reports Second Quarter 2011 Net New Business of $310 million, Revenue of $233 million and EPS of 21c (NASDAQ:ICLR) (ISIN:IE0005711209)
|
|
|
19 July, 2011
|
ICON Shareholders Vote in Favour of All Resolutions at Its Annual General Meeting
|
|
|
14 July, 2011
|
ICON Acquires Firecrest Clinical
|
|
|
26 May, 2011
|
ICON Selected by Pfizer as a Global Strategic Partner for Clinical Research and Development
|
|
|
11 May, 2011
|
ICON Forms Strategic Alliance With Boston Clinical Research Institute
|
|
|
04 May, 2011
|
Investigative Sites Worldwide Rate ICON as a Top CRO According to Industry Survey
|
|
|
21 April, 2011
|
ICON Reports First Quarter 2011 Revenue up 5% to $229 Million and EPS of 21c
|
|
|
20 April, 2011
|
ICON and ACRONET Sign Alliance Agreement in Japan
|
|
|
24 February, 2011
|
ICON Reports Full-Year 2010 Revenue of $900m and EPS of $1.44
|
|
|
14 January, 2011
|
ICON Acquires Oxford Outcomes
|
|
|
18 November, 2010
|
ICON Central Laboratories ‘Stands out as Service Provider that is more often than not Exceeding Sponsors' Expectations'
|
|
|
15 November, 2010
|
ICON and Proteome Sciences Partner for the Delivery of Comprehensive Biomarker Solutions
|
|
|
26 October, 2010
|
ICON Announces Appointment of Cathrin Petty to Board of Directors
|
|
|
21 October, 2010
|
Icon Reports Revenues of $225 Million up 2% on Prior Year (Nasdaq:ICLR) (ISIN:IE0005711209)
|
|
|
20 August, 2010
|
ICON Appoints Alan Morgan To Role Of Group President, Clinical Research Services
|
|
|
27 July, 2010
|
ICON Reports Revenues Up 2% And Strong New Business Wins
|
|
|
20 July, 2010
|
ICON Shareholders Pass All Resolutions at Its Annual General Meeting
|
|
